SQI Withdraws Filings for US IPO; Acquisition of Scienion in Doubt | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Canadian diagnostics firm SQI Diagnostics today announced it has withdrawn its registration forms filed with regulators in the US and Canada for a proposed US initial public offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.